Historical Stock Price
MCRB historical stock prices picture
Seres Therapeutics (MCRB) has the following price history information. Looking back at MCRB historical stock prices for the last five trading days, on March 21, 2024, MCRB opened at $0.83, traded as high as $0.84 and as low as $0.78, and closed at $0.80. Trading volume was a total of 2.65M shares. On March 22, 2024, MCRB opened at $0.80, traded as high as $0.81 and as low as $0.77, and closed at $0.77. Trading volume was a total of 2.57M shares. On March 25, 2024, MCRB opened at $0.78, traded as high as $0.82 and as low as $0.77, and closed at $0.79. Trading volume was a total of 2.72M shares. On March 26, 2024, MCRB opened at $0.80, traded as high as $0.82 and as low as $0.75, and closed at $0.75. Trading volume was a total of 2.72M shares. On March 27, 2024, MCRB opened at $0.76, traded as high as $0.80 and as low as $0.75, and closed at $0.78. Trading volume was a total of 3.30M shares.

MCRB Historical Stock Prices By Date:

MCRB historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Seres Therapeutics shares, starting with a $10,000 purchase of MCRB, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/29/2015
End date: 03/27/2024
Start price/share: $38.00
End price/share: $0.78
Dividends collected/share: $0.00
Total return: -97.95%
Average Annual Total Return: -35.86%
Starting investment: $10,000.00
Ending investment: $205.23
Years: 8.75
Date Open High Low Close Volume
03/21/2024 $0.83 $0.84 $0.78 $0.80 2.65M
03/22/2024 $0.80 $0.81 $0.77 $0.77 2.57M
03/25/2024 $0.78 $0.82 $0.77 $0.79 2.72M
03/26/2024 $0.80 $0.82 $0.75 $0.75 2.72M
03/27/2024 $0.76 $0.80 $0.75 $0.78 3.30M
Seres Therapeutics is a microbiome therapeutics platform company developing live biotherapeutic drugs. SER-109, Co.'s lead clinical candidate is an oral, purified bacterial spore-based microbiome therapeutic candidate consisting of a consortium of purified Firmicutes spores. Using Co.'s microbiome therapeutics platform, Co. is also developing SER-287 and SER-301 to treat ulcerative colitis. Co. evaluates microbiome pharmacokinetic and pharmacodynamic data from across its clinical and pre-clinical portfolios using its reverse translation microbiome therapeutics capabilities to conduct research on various indications, including inflammatory and immune diseases, cancer, and metabolic diseases.
Date Close
03/21/2024$0.80
03/22/2024$0.77
03/25/2024$0.79
03/26/2024$0.75
03/27/2024$0.78
MCRB is categorized under the Healthcare sector; below are some other companies in the same sector:

MD Historical Stock Prices
MDCI Historical Stock Prices
MDCO Historical Stock Prices
MDG Historical Stock Prices
MDGL Historical Stock Prices
MDGN Historical Stock Prices
MDT Historical Stock Prices
MDVN Historical Stock Prices
MDVX Historical Stock Prices
MDX Historical Stock Prices

Also explore: MCRB shares outstanding history

Email EnvelopeFree MCRB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


MCRB Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.